The embryonic transcription factor Hlxb9 is a menin interacting partner that controls pancreatic β-cell proliferation and the expression of insulin regulators

Endocrine-Related Cancer

Volumn 20, Issue 1, 2013, Pages 111-122

  Shi, Kerong ^b   Parekh, Vaishali I ^a   Roy, Swarnava ^c   Desai, Shruti S ^a   Agarwal, Sunita K ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b SHANDONG AGRICULTURAL UNIVERSITY   (China)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Gene expression; Gene regulation; Islet cells; Multiple endocrine neoplasias

Indexed keywords

B LYMPHOCYTE DIFFERENTIATION FACTOR; HEPATOCYTE NUCLEAR FACTOR 3BETA; NEUROGENIC DIFFERENTIATION FACTOR; NEUROGENIN 3; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HLXB 9; TRANSCRIPTION FACTOR MAFB; TRANSCRIPTION FACTOR NKX2.2; TRANSCRIPTION FACTOR NKX6.1; TRANSCRIPTION FACTOR PAX4; TRANSCRIPTION FACTOR PAX6; TRANSCRIPTION FACTOR PDX 1; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE CONTROL; GENE LOSS; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INSULINOMA; MAMMAL CELL; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; RNA ISOLATION; TISSUE SPECIFICITY; UPREGULATION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; EMBRYO, MAMMALIAN; FIBROBLASTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; INSULIN; INSULIN-SECRETING CELLS; INSULINOMA; KIDNEY; MICE; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 84874078253     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-12-0077     Document Type: Article

References (42)

1. Agarwal SK, Guru SC, Heppner C, Erdos MR, Collins RM, Park SY, Saggar S, Chandrasekharappa SC, Collins FS, Spiegel AM et al. 1999 Menin interacts with the AP1 transcription factor JunD and represses JunDactivated transcription. Cell 96 143-152. (doi:10.1016/S0092- 8674(00)80967-8)
2. Ang YS, Tsai SY, Lee DF, Monk J, Su J, Ratnakumar K, Ding J, Ge Y, Darr H, Chang B et al. 2011 Wdr5mediates self-renewal and reprogramming via the embryonic stem cell core transcriptional network. Cell 145 183-197. (doi:10.1016/j.cell.2011.03.003)
3. Balasubramanian D & Scacheri PC 2009 Functional studies of menin through genetic manipulation of the Men1 homolog in mice. Advances in Experimental Medicine and Biology 668 105-115. (doi:10.1002/gene. 1072)
4. Balogh K, Patocs A, Hunyady L & Racz K 2010 Menin dynamics and functional insight: take your partners. Molecular and Cellular Endocrinology 326 80-84. (doi:10.1016/j.mce.2010.04.011)
5. Braunewell KH & Klein-Szanto AJ 2009 Visinin-like proteins (VSNLs): interaction partners and emerging functions in signal transduction of a subfamily of neuronal Ca2C-sensor proteins. Cell and Tissue Research 335 301-316. (doi:10.1007/s00441-008-0716-3)
6. Briegel KJ 2006 Embryonic transcription factors in human breast cancer. IUBMB Life 58 123-132. (doi:10.1080/15216540600686870)
7. Canaff L, Vanbellinghen JF, Kanazawa I, Kwak H, Garfield N, Vautour L & Hendy GN 2012 Menin missense mutants encoded by the MEN1 gene that are targeted to the proteasome: restoration of expression and activity by CHIP siRNA. Journal of Clinical Endocrinology and Metabolism 97 E282-E291. (doi:10.1210/jc.2011-0241)
8. Dai FF, Zhang Y, Kang Y, Wang Q, Gaisano HY, Braunewell KH, Chan CB & Wheeler MB 2006 The neuronal Ca2C sensor protein visinin-like protein-1 is expressed in pancreatic islets and regulates insulin secretion. Journal of Biological Chemistry 281 21942-21953. (doi:10.1074/jbc.M512924200)
9. Fu J, Zhang J, Jin F, Patchefsky J, Braunewell KH & Klein-Szanto AJ 2009 Promoter regulation of the visinin-like subfamily of neuronal calcium sensor proteins by nuclear respiratory factor-1. Journal of Biological Chemistry 284 27577-27586. (doi:10.1074/jbc.M109.049361)
10. Garin I, Martinez R, de las Heras J, Perez-Nanclares G, Castano L & Perez de Nanclares G 2009 Mutations in MAFA and IAPP are not a common cause of monogenic diabetes. Diabetic Medicine 26 746-748. (doi:10.1111/j.1464-5491.2009. 02758.x)
11. Guo RJ, Suh ER & Lynch JP 2004 The role of Cdx proteins in intestinal development and cancer. Cancer Biology & Therapy 3 593-601. (doi:10.4161/cbt.3.7.913)
12. Harrison KA, Thaler J, Pfaff SL, Gu H & Kehrl JH 1999 Pancreas dorsal lobe agenesis and abnormal islets of Langerhans in Hlxb9-deficient mice. Nature Genetics 23 71-75. (doi:10.1038/12674)
13. Huang J, Gurung B, Wan B, Matkar S, Veniaminova NA, Wan K, Merchant JL, Hua X & LeiM2012 The same pocket in menin binds both MLL and JUND but has opposite effects on transcription. Nature 482 542-546. (doi:10.1038/nature10806)
14. Hughes WE, Elgundi Z, Huang P, Frohman MA & Biden TJ 2004 Phospholipase D1 regulates secretagogue-stimulated insulin release in pancreatic b-cells. Journal of Biological Chemistry 279 27534-27541. (doi:10.1074/jbc. M403012200)
15. Jensen RT, Berna MJ, Bingham DB & Norton JA 2008 Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies. Cancer 113 1807-1843. (doi:10.1002/cncr.23648)
16. Jiao Y, Shi C, Edil BH, de Wilde RF, Klimstra DS, Maitra A, Schulick RD, Tang LH, Wolfgang CL, Choti MA et al. 2011 DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science 331 1199-1203. (doi:10.1126/science.1200609)
17. Kimura S 2011 Thyroid-specific transcription factors and their roles in thyroid cancer. Journal of Thyroid Research 2011 710213. (doi:10.4061/ 2011/710213)
18. Knapp JI, Heppner C, Hickman AB, Burns AL, Chandrasekharappa SC, Collins FS, Marx SJ, Spiegel AM & Agarwal SK 2000 Identification and characterization of JunD missense mutants that lack menin binding. Oncogene 19 4706-4712. (doi:10.1038/sj.onc.1203832)
19. Li H & Edlund H 2001 Persistent expression of Hlxb9 in the pancreatic epithelium impairs pancreatic development. Developmental Biology 240 247-253. (doi:10.1006/dbio.2001.0440)
20. Li H, Arber S, Jessell TM & Edlund H 1999 Selective agenesis of the dorsal pancreas in mice lacking homeobox gene Hlxb9. Nature Genetics 23 67-70. (doi:10.1038/12669)
21. Lu J, Herrera PL, Carreira C, Bonnavion R, Seigne C, Calender A, Bertolino P & Zhang CX 2010 a Cell-specific Men1 ablation triggers the transdifferentiation of glucagon-expressing cells and insulinoma development. Gastroenterology 138 1954-1965. (doi:10.1053/j.gastro. 2010.01.046)
22. Lu J, Hamze Z, Bonnavion R, Herath N, Pouponnot C, Assade F, Fontaniere S, Bertolino P, Cordier-Bussat M & Zhang CX 2012 Reexpression of oncoprotein MafB in proliferative b-cells and Men1 insulinomas in mouse. Oncogene 31 3647-3654. (doi:10.1038/ onc.2011.538)
23. Ma WN, Park SY & Han JS 2010 Role of phospholipase D1 in glucoseinduced insulin secretion in pancreatic b cells. Experimental & Molecular Medicine 42 456-464. (doi:10.3858/emm.2010.42.6.047)
24. Melloul D 2004 Transcription factors in islet development and physiology: role of PDX-1 in b-cell function. Annals of the New York Academy of Sciences 1014 28-37. (doi:10.1196/annals.1294.003)
25. Miguel-Aliaga I, Thor S & Gould AP 2008 Postmitotic specification of Drosophila insulinergic neurons from pioneer neurons. PLoS Biology 6 e58. (doi:10.1371/journal.pbio.0060058)
26. Miyazaki J, Araki K, Yamato E, Ikegami H, Asano T, Shibasaki Y, Oka Y & Yamamura K 1990 Establishment of a pancreatic b cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms. Endocrinology 127 126-132. (doi:10.1210/ endo-127-1-126)
27. Murai MJ, Chruszcz M, Reddy G, Grembecka J & Cierpicki T 2011 Crystal structure of menin reveals binding site for mixed lineage leukemia (MLL) protein. Journal of Biological Chemistry 286 31742-31748. (doi:10.1074/jbc.M111. 258186)
28. Nagel S, Kaufmann M, Scherr M, Drexler HG & MacLeod RA 2005 Activation of HLXB9 by juxtaposition with MYB via formation of t(6;7)(q23;q36) in an AML-M4 cell line (GDM-1). Genes, Chromosomes & Cancer 42 170-178. (doi:10.1002/gcc.20113)
29. Naylor R & Philipson LH 2011 Who should have genetic testing for maturity-onset diabetes of the young? Clinical Endocrinology 75 422-426. (doi:10.1111/j.1365-2265.2011.04049.x)
30. Ross AJ, Ruiz-Perez V, Wang Y, Hagan DM, Scherer S, Lynch SA, Lindsay S, Custard E, Belloni E, Wilson DI et al. 1998 A homeobox gene, HLXB9, is the major locus for dominantly inherited sacral agenesis. Nature Genetics 20 358-361. (doi:10.1038/3828)
31. Scacheri PC, Davis S, Odom DT, Crawford GE, Perkins S, Halawi MJ, Agarwal SK, Marx SJ, Spiegel AM, Meltzer PS et al. 2006 Genome-wide analysis of menin binding provides insights into MEN1 tumorigenesis. PLoS Genetics 2 e51. (doi:10.1371/journal.pgen.0020051)
32. Schnepp RW, Mao H, Sykes SM, Zong WX, Silva A, La P & Hua X 2004 Menin induces apoptosis in murine embryonic fibroblasts. Journal of Biological Chemistry 279 10685-10691. (doi:10.1074/jbc.M308073200)
33. Shen HC, He M, Powell A, Adem A, Lorang D, Heller C, Grover AC, Ylaya K, Hewitt SM, Marx SJ et al. 2009 Recapitulation of pancreatic neuroendocrine tumors in human multiple endocrine neoplasia type I syndrome via Pdx1-directed inactivation of Men1. Cancer Research 69 1858-1866. (doi:10.1158/0008-5472.CAN- 08-3662)
34. Shen HC, Ylaya K, Pechhold K, Wilson A, Adem A, Hewitt SM & Libutti SK 2010 Multiple endocrine neoplasia type 1 deletion in pancreatic a-cells leads to development of insulinomas in mice. Endocrinology 151 4024-4030. (doi:10.1210/en.2009-1251)
35. Sherr CJ 2004 Principles of tumor suppression. Cell 116 235-246. (doi:10.1016/S0092-8674(03)01075-4)
36. Smith E, Lin C & Shilatifard A 2011 The super elongation complex (SEC) and MLL in development and disease. Genes and Development 25 661-672. (doi:10.1101/gad.2015411)
37. Thakker RV 2010 Multiple endocrine neoplasia type 1 (MEN1). Best Practice & Research. Clinical Endocrinology & Metabolism 24 355-370. (doi:10.1016/j.beem.2010.07.003)
38. Thaler J, Harrison K, Sharma K, Lettieri K, Kehrl J & Pfaff SL 1999 Active suppression of interneuron programs within developing motor neurons revealed by analysis of homeodomain factor HB9. Neuron 23 675-687. (doi:10.1016/S0896-6273(01)80027-1)
39. Wang Y, Ozawa A, Zaman S, Prasad NB, Chandrasekharappa SC, Agarwal SK & Marx SJ 2011 The tumor suppressor protein menin inhibits AKT activation by regulating its cellular localization. Cancer Research 71 371-382. (doi:10.1158/0008-5472.CAN-10-3221)
40. Wildenhain S, Ruckert C, Röttgers S, Harbott J, Ludwig WD, Schuster FR, Beldjord K, Binder V, Slany R, Hauer J & Borkhardt A 2010 Expression of cell-cell interacting genes distinguishes HLXB9/TEL from MLL-positive childhood acute myeloid leukemia. Leukemia 24 1657-1660. (doi:10.1038/leu.2010.146)
41. William CM, Tanabe Y & Jessell TM 2003 Regulation of motor neuron subtype identity by repressor activity of Mnx class homeodomain proteins. Development 130 1523-1536. (doi:10.1242/dev.00358)
42. Yokoyama A, Somervaille TC, Smith KS, Rozenblatt-Rosen O, Meyerson M & Cleary ML 2005 The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis. Cell 123 207-218. (doi:10.1016/j.cell.2005.09.025)